BioPharm International
September 02, 2011
Features
2011 Supplement
6
Inside the National Institutes of Health
September 02, 2011
Features
2011 Supplement
6
Developing a quality agreement template for single-use systems.
September 02, 2011
Features
2011 Supplement
6
Market considerations and new technologies must be recognized to achieve the full benefits of manufacturing prefilled syringes.
September 02, 2011
Features
2011 Supplement
6
An interview with Oskar Gold, vice-president, key account management and corporate marketing, at Vetter.
September 02, 2011
Features
2011 Supplement
6
The lower price of biosimilars will increase patient access to medicines and spur innovation.
September 02, 2011
Features
2011 Supplement
6
The market landscape for biosimilars is in flux, with limited penetration now, but with the potential for growth for those who can navigate the market. Plus: A SWOT analysis of biosimilars by Anjan Selz.
September 01, 2011
Issue PDF
2011 Supplement
6
Biopharmaceutical Trends Report